# The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019, Regulation 10: Amendment of regulation 21 (clinical trials conducted in third countries)


(1) Regulation 21 is amended as follows.
(2) In the heading, for “third countries” substitute “countries other than the United Kingdom”.
(3) In paragraph (1), for “a third” substitute “another”.

---
Source: https://www.legislation.gov.uk/ukdsi/2019/9780111179116/regulation/10 (the official version)
Page: https://openlegislation.uk/draft-medicines-for-human-use-clinical-trials-amendment-eu-exit-regulations-2019/regulation-10
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.